Journal
TRENDS IN CARDIOVASCULAR MEDICINE
Volume 24, Issue 3, Pages 121-127Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2013.09.004
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA128919] Funding Source: Medline
- NHLBI NIH HHS [R01 HL096498] Funding Source: Medline
Ask authors/readers for more resources
A number of genetic diseases in man have been described in which abnormalities in the development and function of the lymphatic vascular (LV) system are prominent features. The genes that are mutated in these diseases are varied and include genes that encode lymphatic endothelial cell (LEC) growth factor receptors and their ligands and transcription factors that control LEC fate and function. In addition, an increasing number of genes have been identified that encode components of the Ras signal transduction pathway that conveys signals from cell surface receptors to regulate cell growth, proliferation, and differentiation. Gene targeting studies performed in mice have confirmed that the LV system is particularly susceptible to perturbations in the Ras pathway. (C) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available